EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis

Hidi A A Abdellatif, Basma Osman Sultan, Hassnaa M Nassar, Mostafa Elsaied Elsayed Gomaa, Mohamed Gamal Sakr, Eman Riad, Alhanouf I Al-Harbi iD, Jawaher A Abdulhakim iD, Manal S Fawzy iD, Noha M Abd El-Fadeal iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24087177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hidi A A Abdellatif und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt. Hauptthemen laut MEDLINE: COVID-19, Acute Kidney Injury. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Urokinase receptors regulate the interplay between inflammation, immunity, and blood clotting. The soluble urokinase plasminogen activator system is an immunologic regulator affecting endothelial function and its related receptor; the soluble urokinase plasminogen activator receptor (suPAR) has been reported to impact kidney injury. This work aims to measure serum levels of suPAR in COVID-19 patients and correlate the measurements with variable clinicolaboratory parameters and patient outcomes. In this prospective cohort study, 150 COVID-19 patients and 50 controls were included. The circulating suPAR levels were quantified by Enzyme-linked immunosorbent assay (ELISA). Routine COVID-19 laboratory assessments, including CBC, CRP, LDH, serum creatinine, and estimated glomerular filtration rates, were performed. The need for oxygen therapy, CO-RAD score, and survival rates was assessed. Bioinformatic analysis and molecular docking were run to explore the urokinase receptor structure/function and to characterize molecules as potential anti-suPAR therapeutic targets, respectively. We found higher circulating suPAR levels in COVID-19 patients vs. controls (p < 0.001). Circulating suPAR levels positively correlated with COVID-19 severity, the need for O2 therapy, the total leukocytes count, and the neutrophils to lymphocyte ratio, while they were negatively correlated with the O2 saturation level, albumin, blood calcium, lymphocytic count, and GFR. In addition, the suPAR levels were associated with poor prognostic outcomes such as a high incidence of acute kidney injury (AKI) and mortality rate. Kaplan–Meier curves showed a lower survival rate with higher suPAR levels. The logistic regression analysis confirmed the significant association of suPAR levels with the occurrence of AKI related to COVID-19 and with increased mortality probability within three months of COVID-19 follow-up. Some compounds that can act similarly to uPAR were discovered and tested by molecular docking to identify the possible ligand–protein interactions. In conclusion, higher circulating suPAR levels were associated with COVID-19 severity and could be considered a putative predictor of AKI development and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Acute Kidney InjuryHumansReceptors, Urokinase Plasminogen ActivatorProspective StudiesUrokinase-Type Plasminogen ActivatorMolecular Docking SimulationBiomarkers

Stichwörter der Autor:innen

AKICD87COVID-19PLAURmortalitysuPAR

Substanzen

Receptors, Urokinase Plasminogen ActivatorUrokinase-Type Plasminogen ActivatorBiomarkers

Autor:innen und Institutionen

  • Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
  • Oncology Diagnostic Unit, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
  • Internal Medicine Department-Nephrology Unit, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
  • Clinical Pathology Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
  • Anesthesia and Intensive Care Department, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.
  • Internal Medicine Department-Tropical Medicine, Faculty of Medicine, Suez Canal University, Ismailia 41522, Egypt.

ORCID-Profile: Alhanouf I Al-Harbi, Jawaher A Abdulhakim, Manal S Fawzy, Noha M Abd El-Fadeal

Zitieren

APA

Abdellatif, H. A. A., Sultan, B. O., Nassar, H. M., Gomaa, M. E. E., Sakr, M. G., Riad, E., Al-Harbi, A. I., Abdulhakim, J. A., Fawzy, M. S., & Abd El-Fadeal, N. M. (2023). Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087177

Vancouver

Abdellatif HAA, Sultan BO, Nassar HM, Gomaa MEE, Sakr MG, Riad E, et al. Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087177

BibTeX
@article{Abdellatif2023,
  author = {Abdellatif, Hidi A A and Sultan, Basma Osman and Nassar, Hassnaa M and Gomaa, Mostafa Elsaied Elsayed and Sakr, Mohamed Gamal and Riad, Eman and Al-Harbi, Alhanouf I and Abdulhakim, Jawaher A and Fawzy, Manal S and Abd El-Fadeal, Noha M},
  title = {Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24087177}
}
Kostenlos starten →